m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00655)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
SAV1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by ALKBH5 | ||
Cell Line | 143B cell line | Homo sapiens |
Treatment: siALKBH5 transfected 143B cells
Control: siControl 143B cells
|
GSE154528 | |
Regulation |
|
logFC: -1.29E+00 p-value: 1.15E-10 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Inhibiting ALKBH5 in Multiple Myeloma cells increased Protein salvador homolog 1 (SAV1) m6A levels, decreased SAV1 mRNA stability and expression, suppressed the stem cell related HIPPO-pathway signalling and ultimately activates the downstream effector YAP, exerting an anti-myeloma effect. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Multiple myeloma | ICD-11: 2A83.1 | ||
Pathway Response | Hippo signaling pathway | hsa04390 | ||
Cell Process | Cell proliferation | |||
Cell invasion | ||||
In-vitro Model | U266 (Human multiple myeloma cells) | |||
RPMI-8226 | Plasma cell myeloma | Homo sapiens | CVCL_0014 | |
NCI-H929 | Plasma cell myeloma | Homo sapiens | CVCL_1600 | |
ARH-77 | Human leukemia tumor | Homo sapiens | CVCL_1072 | |
Multiple myeloma [ICD-11: 2A83]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Inhibiting ALKBH5 in Multiple Myeloma cells increased Protein salvador homolog 1 (SAV1) m6A levels, decreased SAV1 mRNA stability and expression, suppressed the stem cell related HIPPO-pathway signalling and ultimately activates the downstream effector YAP, exerting an anti-myeloma effect. | |||
Responsed Disease | Multiple myeloma [ICD-11: 2A83.1] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Pathway Response | Hippo signaling pathway | hsa04390 | ||
Cell Process | Cell proliferation | |||
Cell invasion | ||||
In-vitro Model | U266 (Human multiple myeloma cells) | |||
RPMI-8226 | Plasma cell myeloma | Homo sapiens | CVCL_0014 | |
NCI-H929 | Plasma cell myeloma | Homo sapiens | CVCL_1600 | |
ARH-77 | Human leukemia tumor | Homo sapiens | CVCL_1072 | |